FRANKFURT (Reuters) -Bayer said on Monday that it welcomed a new law about to be passed in the U.S. state of Georgia to ...
Bayer, the corporation behind Roundup herbicide, has paid out nearly $11 billion in lawsuits. Trump's EPA might move to block ...
The EU has recently approved the use of glyphosate for another decade. Bárbara Pinho examines the controversial pesticide's ...
Recent health news highlights include Bayer's optimism over Georgia's new law against glyphosate litigation, AstraZeneca's $1 ...
FRANKFURT, March 17 (Reuters) - Bayer (BAYGn.DE), opens new tab said ... protect the maker of crop protection chemicals against glyphosate litigation. The company said in a statement to Reuters ...
The Cool Down on MSN6h
Researchers link concerning factor to uptick in birth complications: 'Current regulations may be inadequate'"Historically disadvantaged groups disproportionately bear these health effects." Researchers link concerning factor to ...
Current health news highlights include Bayer's support for a new U.S. law on glyphosate litigation, WHO's warning on Afghan healthcare funding shortages, and AstraZeneca's $1 billion acquisition of ...
Today’s Oval Office display is part of a growing trend of Trump and his acolytes jumping to defend Musk’s character, painting the world’s wealthiest person — who has led the dramatic slashing of the ...
In this opinion piece, David Carpenter, vice president of development and chief legal officer for Green Lantern Solar, argues that farmers should have the right to determine the best uses of their ...
Bayer’s consumer health business benefits from a narrow economic moat, largely because of its strong brand power. Consumers continue to pay a premium for Aspirin, Aleve, and other over-the-counter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback